These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 33102164

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Red blood cell alloimmunisation in sickle cell disease patients in the Democratic Republic of the Congo.
    Kambale-Kombi P, Djang'eing'a RM, Alworong'a Opara JP, Minon JM, Sepulchre E, Bours V, Floch A, Pirenne F, Tshilumba CK, Batina-Agasa S.
    Transfus Med; 2023 Apr; 33(2):137-146. PubMed ID: 36377544
    [Abstract] [Full Text] [Related]

  • 4. Utilising red cell antigen genotyping and serological phenotyping in sickle cell disease patients to risk-stratify patients for alloimmunisation risk.
    Shih AW, Yan MTS, Elahie AL, Barty RL, Liu Y, Berardi P, Azzam M, Siddiqui R, Parvizian MK, Mcdougall T, Heddle NM, Al-Habsi KS, Goldman M, Cote J, Athale U, Verhovsek MM.
    Transfus Med; 2020 Aug; 30(4):263-274. PubMed ID: 32432400
    [Abstract] [Full Text] [Related]

  • 5. Red Cell Alloimmunisation Among Sickle Cell Disease and Thalassemia Patients Following Rh- and K-Matched Red Cell Transfusion in Southwestern Saudi Arabia: A Multicenter Study.
    Meshi AA, Abu-Tawil H, Hamzi AA, Madkhali BA, Maghfori AB, Alnami II, Hamali HA, Madkhali MM.
    Int J Gen Med; 2024 Aug; 17():2855-2864. PubMed ID: 38947563
    [Abstract] [Full Text] [Related]

  • 6. Red blood-cell alloantibodies in multiply transfused patients in the occupied Palestinian territory: a pilot study.
    Yaseen A, Suleiman S, Zenah OA, Abu Taha A.
    Lancet; 2018 Feb 21; 391 Suppl 2():S4. PubMed ID: 29553439
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. HLA-F and LILRB1 Genetic Polymorphisms Associated with Alloimmunisation in Sickle Cell Disease.
    Bernit E, Jean E, Marlot B, Laget L, Izard C, Dettori I, Beley S, Gautier I, Agouti I, Frassati C, Pedini P, Picard C, Paganini J, Chiaroni J, Di Cristofaro J.
    Int J Mol Sci; 2023 Sep 02; 24(17):. PubMed ID: 37686397
    [Abstract] [Full Text] [Related]

  • 10. Red cell alloimmunisation in regularly transfused beta thalassemia patients in Pakistan.
    Zaidi U, Borhany M, Ansari S, Parveen S, Boota S, Shamim I, Zahid D, Shamsi T.
    Transfus Med; 2015 Apr 02; 25(2):106-10. PubMed ID: 25870030
    [Abstract] [Full Text] [Related]

  • 11. The erythrocyte alloimmunisation in patients with sickle cell anaemia: a systematic review.
    da Cunha Gomes EG, Machado LAF, de Oliveira LC, Neto JFN.
    Transfus Med; 2019 Jun 02; 29(3):149-161. PubMed ID: 29845661
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Alloimmunisation in thalassaemics: a comparison between recipients of usual matched and partial better matched blood. An evaluation at a tertiary care centre in India.
    Pujani M, Pahuja S, Dhingra B, Chandra J, Jain M.
    Blood Transfus; 2014 Jan 02; 12 Suppl 1(Suppl 1):s100-4. PubMed ID: 23399366
    [Abstract] [Full Text] [Related]

  • 14. Red blood cell alloimmunisation in multi-transfused patients from an haemodialysis service in Burkina Faso.
    Nebie K, Sawadogo S, Sawadogo S, Koulidiati J, Lengani HYA, Sawadogo AG, Babinet J, Khalloufi M, Diop S, Kafando E.
    Afr J Lab Med; 2022 Jan 02; 11(1):1625. PubMed ID: 36263390
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. HLA polymorphisms and risk of red blood cell alloimmunisation in polytransfused patients with sickle cell anaemia.
    Rodrigues C, Sell AM, Guelsin GAS, Higa TT, Pagliarini E Silva S, Macedo LC, Sippert EÂ, de Alencar JB, Zanette Â, Acorsi CRL, Castilho L, Visentainer JEL.
    Transfus Med; 2017 Dec 02; 27(6):437-443. PubMed ID: 28881103
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.